Ethos Biosciences
- Company typePrivate
- Founded2018
- HeadquartersNewtown Square, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Ethos Biosciences firmographics
Firmographics- Name
- Ethos Biosciences
- Legal name
- Ethos Biosciences, Inc.
- Website
- https://ethosbiosciences.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Ethos Biosciences industry classification
Industry- Product category
- In Vitro Diagnostics (IVD) Reagents and Stains
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Ethos Biosciences is headquartered
LocationHeadquarters
- HQ city
- Newtown Square
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ethos Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Standard Diagnostic Reagent Products: Ethos generates revenue through the sale of standard diagnostic reagents, stains, and assay components across histology, cytology, hematology, microbiology, and general laboratory categories. Products are sold via e-commerce storefront and direct sales, with pricing ranging from approximately $12 to over $700 per unit depending on product type and volume.
- Custom Reagent Development Services: Ethos develops custom reagent formulations based on specific customer application requirements, moving from feasibility through production. This development services revenue is project-based.
- Private Label / OEM Manufacturing: Ethos offers private label manufacturing programs (OEM/CDMO) for companies seeking to develop and manufacture diagnostic products under their own brand, with focus on custom formulation, regulatory readiness, and scalable production.
- Immunoassay Development Services: Development and manufacturing of antibody-based assays including ELISA kit development and lateral flow assay development, with performance targets defined by real-world use conditions. These services include both development fees and potential ongoing kit supply.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Per-unit product pricing across standard catalog |
| Unit Pricing | Monthly | Minimum order policy and payment terms |
| Other | Multi-year contract | Custom OEM/private label programs — quote-based |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Ethos Biosciences product offering
Product offeringCore offering
Ethos Biosciences designs, develops, and manufactures precision diagnostic reagents, stains, and assay components and kits — including histology, hematology, microbiology, cytology, and general laboratory reagents, plus Exocell ELISA kits (albumin and cystatin C) for nephrology — through a fully integrated manufacturing process covering raw materials, formulation, production, and quality control at an ISO 13485-certified U.S. facility. The company also delivers custom reagent development, immunoassay (ELISA and lateral flow) development, and OEM/private label manufacturing services for partners seeking to bring diagnostic products to market under their own brand.
Product overview
Ethos Biosciences develops and manufactures precision diagnostic reagents, stains, and assay components for clinical and research laboratories. The company operates as a fully integrated manufacturer controlling the entire process from raw materials through formulation, production, and quality control. The product portfolio includes histology reagents, hematology reagents and dyes, microbiology reagents, cytology reagents, and general laboratory chemicals sold primarily under the Astral Diagnostics brand. The immunoassay offerings include Exocell albumin ELISAs and Cystatin C ELISAs for nephrology research. Specialized staining products include Papanicolaou stains (EA-36, EA-50, EA-65, OG-6), Hematoxylin stains (Gill, Harris, Mayer's), Wright/Wright-Giemsa stains, Gram stains, and Acid Fast stains (Ziehl-Neelsen, Kinyoun). Services include Custom Reagent Development, Private Label Manufacturing (OEM/CDMO), and Immunoassay Development (ELISA Kit and Lateral Flow Assay development and manufacturing). Products are designed for accuracy, repeatability, and compatibility with both manual and automated staining systems.
Differentiator
Problem solved
Functional benefit
Products and services
- Histology Reagents & Tissue Processing Chemicals Reagents used in tissue preparation and staining, designed to produce stable, interpretable results across manual and automated systems for clinical and research histology laboratories.
- Hematology Reagents & Dyes Reagents and dyes developed for blood analysis, supporting consistent staining behavior and reliable identification of cellular components in hematology workflows (includes Wright, Wright-Giemsa, and Quick stains).
- Microbiology Reagents Reagents designed to aid organism identification and analysis, including Gram stain products (Crystal Violet, Iodine, Decolorizer) and acid fast stains (Ziehl-Neelsen and Kinyoun), with formulations supporting visualization and reproducible results.
- Cytology Reagents Stains and reagents used to highlight the cellular detail needed for diagnostic interpretations in cytology, including Papanicolaou stains (EA-36, EA-50, EA-65, OG-6), Hematoxylin nuclear stains (Gill, Harris, Mayer's), and the EASYpap single-step solution.
- General Laboratory Reagents Chemicals and solutions used across laboratory processes, formulated for stability and repeatable performance, sold primarily under the Astral Diagnostics brand.
- Exocell Albumin and Cystatin C ELISA Kits ELISA kits for quantitative detection of albumin and cystatin C in human, mouse, and rat samples, supporting kidney function assessment and nephrology research with over 2,100 publications citing the kits.
- ELISA Kit Development & Manufacturing Custom ELISA kit development and manufacturing service, designing plate-based assays for laboratory environments where quantitative results and reproducibility are required, with project-based development fees.
- Lateral Flow Assay Development & Manufacturing Development and manufacturing of antibody-based lateral flow assays designed for ease-of-use and consistent performance outside traditional laboratory settings, with performance targets defined by real-world use conditions.
- Private Label Manufacturing (OEM/CDMO) Quote-driven, project-specific private label and OEM/CDMO programs built around custom formulation, regulatory readiness, and scalable GMP production for companies commercializing diagnostic products under their own brand.
- Custom Reagent Development Project-based custom reagent development service adapting or developing formulations based on specific customer application requirements, moving from feasibility through production.
Quantifiable outcome
- Over 2,100 scientific publications worldwide citing Ethos Biosciences' ELISA kits, indicating widespread adoption and credibility in nephrology and biomedical research.
- +1 more outcomes
Companies that use Ethos Biosciences
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Ethos Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Ethos Biosciences partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Ethos Biosciences competitors and assessment
Company assessmentDirect peers
- Abcam: Direct peer in research antibodies, ELISA kits, and IVD reagents, with a comparable e-commerce-led distribution model and emphasis on reagent validation and citations in peer-reviewed publications.
- Medix Biochemica: Direct peer as a specialized IVD raw material and OEM reagent manufacturer with antibody and immunoassay capabilities, competing for similar private-label and OEM diagnostic partnerships.
- Bio-Rad Laboratories: Direct competitor in clinical diagnostics reagents, ELISA kits, and IVD manufacturing with overlapping hematology, histology, and immunology product lines serving similar clinical and research lab customers.
- Bio-Techne (R&D Systems): Direct peer in ELISA kits (including renal biomarkers like cystatin C), antibodies, and research reagents, with a comparable focus on reproducible quantitative assays for biomedical research customers.
- Cell Signaling Technology: Direct peer in antibody-based assays and ELISA kits for research and clinical markets, with comparable specialization in validated reagents cited extensively in scientific literature.
- GenScript: Direct peer in custom reagent development, antibody and ELISA kit manufacturing, and OEM services for diagnostic partners — overlapping Ethos's CDMO and immunoassay development offerings.
Broad incumbents
- Millipore Sigma (Merck KGaA): Broad incumbent supplying general lab reagents, stains, dyes, and immunoassay tools to the same clinical and research lab customer base as Ethos, with global distribution advantages.
- Agilent Technologies: Broad incumbent in life science and diagnostics with reagent, immunoassay, and pathology offerings — competes with Ethos in clinical lab workflows but operates a much wider portfolio.
- Thermo Fisher Scientific: Broad incumbent across life sciences with extensive reagent, ELISA, histology, and IVD offerings — competes with Ethos in nearly every catalog category but does not focus on the kidney-disease niche.
Regional players
- Gold Standard Diagnostics: Diagnostic reagent and kit manufacturer overlapping Ethos in veterinary and clinical diagnostics, and notably an existing Ethos customer — useful as a comparable business-model and OEM partner reference.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Ethos Biosciences social profiles
Digital presenceEthos Biosciences compliance and trust
Trust signalCompliance2 records
Ethos Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ethos Biosciences leadership team
Management profileNumber of profiles
Ethos Biosciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ethos Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ethos Biosciences
What does Ethos Biosciences do?
Ethos Biosciences designs, develops, and manufactures precision diagnostic reagents, stains, and assay components and kits — including histology, hematology, microbiology, cytology, and general laboratory reagents, plus Exocell ELISA kits (albumin and cystatin C) for nephrology — through a fully integrated manufacturing process covering raw materials, formulation, production, and quality control at an ISO 13485-certified U.S. facility. The company also delivers custom reagent development, immunoassay (ELISA and lateral flow) development, and OEM/private label manufacturing services for partners seeking to bring diagnostic products to market under their own brand.
Is Ethos Biosciences a public or private company?
Ethos Biosciences is a private company. It is classified as unknown and is currently operating.
When was Ethos Biosciences founded?
Ethos Biosciences was founded in 2018. It employs 1 to 10 people.
Where is Ethos Biosciences based?
Ethos Biosciences is headquartered in Newtown Square, United States, in the North America region.
How does Ethos Biosciences make money?
Four revenue lines are on record. Standard Diagnostic Reagent Products are the primary driver. The others are custom Reagent Development Services, private Label / OEM Manufacturing and immunoassay Development Services.
Who are Ethos Biosciences's main competitors?
Direct peers on record are Abcam, Medix Biochemica, Bio-Rad Laboratories, Bio-Techne (R&D Systems), Cell Signaling Technology and GenScript. Broad incumbents are Millipore Sigma (Merck KGaA), Agilent Technologies and Thermo Fisher Scientific. Gold Standard Diagnostics is listed as a regional player.
Does Ethos Biosciences have an API?
No public API is recorded for Ethos Biosciences.
What industry is Ethos Biosciences in?
Ethos Biosciences's product category is In Vitro Diagnostics (IVD) Reagents and Stains. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.